Sorriso Pharmaceuticals picks up $31m Series A
Sorriso Pharmaceuticals, a provider of anti-inflammatory antibody therapy, has secured $31 million in Series A financing.
Sorriso Pharmaceuticals, a provider of anti-inflammatory antibody therapy, has secured $31 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination